FRA:MRK - Merck KGaA Stock Price, News, & Analysis

€96.32
+1.88 (+1.99 %)
(As of 07/23/2019 07:22 AM ET)
Today's Range
€94.74
Now: €96.32
€96.32
50-Day Range
€88.28
MA: €92.37
€95.52
52-Week Range
€76.60
Now: €96.32
€115.00
Volume151,229 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and performance materials sectors worldwide. It offers prescription medicines to treat cancer, multiple sclerosis, infertility, growth deficiencies, type 2 diabetes, cardiovascular and thyroid diseases, as well as squamous cell carcinoma of the head and neck; diagnostics and prescription drugs for allergen immunotherapy; and fertility treatments. Read More…

Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+49-6151-720

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees51,039
Next Earnings DateN/A
OptionableOptionable

Receive MRK News and Ratings via Email

Sign-up to receive the latest news and ratings for MRK and its competitors with MarketBeat's FREE daily newsletter.

Merck KGaA (FRA:MRK) Frequently Asked Questions

What is Merck KGaA's stock symbol?

Merck KGaA trades on the FRA under the ticker symbol "MRK."

What price target have analysts set for MRK?

20 brokerages have issued 1-year target prices for Merck KGaA's shares. Their predictions range from €82.00 to €111.00. On average, they expect Merck KGaA's share price to reach €100.53 in the next twelve months. This suggests a possible upside of 4.4% from the stock's current price. View Analyst Price Targets for Merck KGaA.

What is the consensus analysts' recommendation for Merck KGaA?

20 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Merck KGaA in the last year. There are currently 1 sell rating, 14 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Merck KGaA.

Has Merck KGaA been receiving favorable news coverage?

Press coverage about MRK stock has trended somewhat negative recently, InfoTrie Sentiment reports. The research group identifies positive and negative news coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Merck KGaA earned a daily sentiment score of -1.8 on InfoTrie's scale. They also assigned media headlines about the healthcare company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the stock's share price in the near term. View News Stories for Merck KGaA.

Who are some of Merck KGaA's key competitors?

What other stocks do shareholders of Merck KGaA own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Merck KGaA investors own include Cisco Systems (CSCO), Micron Technology (MU), Pluristem Therapeutics (PSTI), NVIDIA (NVDA), Boeing (BA), HDFC Bank (HDB), Netflix (NFLX), QUALCOMM (QCOM), Starbucks (SBUX) and Bank of America (BAC).

Who are Merck KGaA's key executives?

Merck KGaA's management team includes the folowing people:
  • Dr. Stefan Oschmann, Chairman of Exec. Board & CEO (Age 62)
  • Dr. Marcus Kuhnert, CFO & Member of Exec. Board (Age 51)
  • Dr. Kai Beckmann, CEO of Performance Materials & Member of the Exec. Board (Age 54)
  • Dr. Udit Batra, CEO of Life Science & Member of Exec. Board (Age 48)
  • Ms. Belén Garijo López M.D., CEO of Healthcare & Member of the Exec. Board (Age 59)

What is Merck KGaA's stock price today?

One share of MRK stock can currently be purchased for approximately €96.32.

What is Merck KGaA's official website?

The official website for Merck KGaA is http://www.merckgroup.com/.

How can I contact Merck KGaA?

Merck KGaA's mailing address is Frankfurter Strasse 250, DARMSTADT, 64293, Germany. The healthcare company can be reached via phone at +49-6151-720.


MarketBeat Community Rating for Merck KGaA (FRA MRK)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  765 (Thanks for Voting!)
Underperform Votes:  868 (Thanks for Voting!)
Total Votes:  1,633
MarketBeat's community ratings are surveys of what our community members think about Merck KGaA and other stocks. Vote "Outperform" if you believe MRK will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MRK will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/23/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel